InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the complete record of transactions filed by Brennan Daniel J., Chief Financial Officer. Director active across 2 companies, notably Nuance Communications, Inc.. Cumulatively, 11 disclosures have been published. Total volume traded: €436k. The latest transaction was disclosed on 2 March 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations11 total
4,519 shares
Common Stock
SEC:0000899243-22-009444:0·
€436,23511,029 shares@ €39.55340.0003% mcap62.9% of flow
Common Stock
SEC:0001225208-22-004108:0·
04,481 shares0
Common Stock
SEC:0001225208-22-003855:0·
€257,35116,863 shares@ €15.26130.0002% mcap37.1% of flow
Common Stock
SEC:0001225208-22-003275:0·
03,661 shares0
Common Stock
SEC:0001225208-22-003072:0·
04,583 shares0
Common Stock
SEC:0001225208-22-002913:0·
04,153 shares0
Common Stock
SEC:0001225208-22-002658:0·
€44,519 shares@ €0.0009100.0% of flow
Common Stock
SEC:0001002517-22-000006·
€44,519 shares@ €0.000950.0% of flow
Common Stock
SEC:0001002517-22-000006:0·
013,193 shares0
Common Stock
SEC:0001225208-22-000106·
013,193 shares0
Common Stock
SEC:0001225208-22-000106:0·
11 of 11 declarations
About Brennan Daniel J.
Daniel J. Brennan serves as the Chief Financial Officer at Boston Scientific Corp and Nuance Communications, Inc. He is responsible for financial management and strategy for both companies. His expertise is crucial in ensuring the financial strength and growth of these firms.
